XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated and Combined Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance at Dec. 31, 2020 $ 59,493   $ 222,949 $ (163,429) $ (27)
Beginning balance (in shares) at Dec. 31, 2020   34,047,300      
Net loss (13,399)     (13,399)  
Issuance of common stock upon exercise of stock options, RSUs and employee stock purchase plan 27   27    
Issuance of common stock upon exercise of stock options, RSUs and employee stock purchase plan (in shares)   82,625      
Share-based compensation expense related to issuance of stock options and RSUs to employees and employee stock purchase plan 1,921   1,921    
Foreign currency translation adjustment (loss) gain 391   391    
Ending balance at Mar. 31, 2021 48,433   225,288 (176,828) (27)
Ending balance (in shares) at Mar. 31, 2021   34,129,925      
Beginning balance at Dec. 31, 2021 $ 48,246   263,345 (215,076) (23)
Beginning balance (in shares) at Dec. 31, 2021 43,410,185 43,410,185      
Net loss $ (12,978)     (12,978)  
Issuance of common stock upon exercise of stock options, RSUs and employee stock purchase plan (in shares)   38,175      
Share-based compensation expense related to issuance of stock options and RSUs to employees and employee stock purchase plan 1,476   1,476    
Share‑based compensation expense related to issuance of stock options to non-employees 291   291    
Foreign currency translation adjustment (loss) gain (1)       (1)
Ending balance at Mar. 31, 2022 $ 37,034   $ 265,112 $ (228,054) $ (24)
Ending balance (in shares) at Mar. 31, 2022 43,448,360 43,448,360